These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30427309)

  • 1. High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types.
    Blanc L; Daudelin IB; Podell BK; Chen PY; Zimmerman M; Martinot AJ; Savic RM; Prideaux B; Dartois V
    Elife; 2018 Nov; 7():. PubMed ID: 30427309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of Mycobacterial Biomarkers and Tuberculosis Drugs in Infected Tissue by MALDI-MS Imaging.
    Blanc L; Lenaerts A; Dartois V; Prideaux B
    Anal Chem; 2018 May; 90(10):6275-6282. PubMed ID: 29668262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Anti-tuberculosis Drugs Reach Their Target?─High-Resolution Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Provides Information on Drug Penetration into Necrotic Granulomas.
    Kokesch-Himmelreich J; Treu A; Race AM; Walter K; Hölscher C; Römpp A
    Anal Chem; 2022 Apr; 94(14):5483-5492. PubMed ID: 35344339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.
    Kjellsson MC; Via LE; Goh A; Weiner D; Low KM; Kern S; Pillai G; Barry CE; Dartois V
    Antimicrob Agents Chemother; 2012 Jan; 56(1):446-57. PubMed ID: 21986820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between sterilizing activity and drug distribution into tuberculosis lesions.
    Prideaux B; Via LE; Zimmerman MD; Eum S; Sarathy J; O'Brien P; Chen C; Kaya F; Weiner DM; Chen PY; Song T; Lee M; Shim TS; Cho JS; Kim W; Cho SN; Olivier KN; Barry CE; Dartois V
    Nat Med; 2015 Oct; 21(10):1223-7. PubMed ID: 26343800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.
    Rifat D; Prideaux B; Savic RM; Urbanowski ME; Parsons TL; Luna B; Marzinke MA; Ordonez AA; DeMarco VP; Jain SK; Dartois V; Bishai WR; Dooley KE
    Sci Transl Med; 2018 Apr; 10(435):. PubMed ID: 29618565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations.
    Sarathy J; Blanc L; Alvarez-Cabrera N; O'Brien P; Dias-Freedman I; Mina M; Zimmerman M; Kaya F; Ho Liang HP; Prideaux B; Dietzold J; Salgame P; Savic RM; Linderman J; Kirschner D; Pienaar E; Dartois V
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30803965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating High-Resolution MALDI Imaging into the Development Pipeline of Anti-Tuberculosis Drugs.
    Treu A; Kokesch-Himmelreich J; Walter K; Hölscher C; Römpp A
    J Am Soc Mass Spectrom; 2020 Nov; 31(11):2277-2286. PubMed ID: 32965115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach.
    Pienaar E; Sarathy J; Prideaux B; Dietzold J; Dartois V; Kirschner DE; Linderman JJ
    PLoS Comput Biol; 2017 Aug; 13(8):e1005650. PubMed ID: 28817561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas.
    Walter K; Kokesch-Himmelreich J; Treu A; Waldow F; Hillemann D; Jakobs N; Lemm AK; Schwudke D; Römpp A; Hölscher C
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0158821. PubMed ID: 34871095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.
    Prideaux B; Dartois V; Staab D; Weiner DM; Goh A; Via LE; Barry CE; Stoeckli M
    Anal Chem; 2011 Mar; 83(6):2112-8. PubMed ID: 21332183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular Pharmacodynamic Modeling Is Predictive of the Clinical Activity of Fluoroquinolones against Tuberculosis.
    Donnellan S; Aljayyoussi G; Moyo E; Ardrey A; Martinez-Rodriguez C; Ward SA; Biagini GA
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions.
    Ordonez AA; Wang H; Magombedze G; Ruiz-Bedoya CA; Srivastava S; Chen A; Tucker EW; Urbanowski ME; Pieterse L; Fabian Cardozo E; Lodge MA; Shah MR; Holt DP; Mathews WB; Dannals RF; Gobburu JVS; Peloquin CA; Rowe SP; Gumbo T; Ivaturi VD; Jain SK
    Nat Med; 2020 Apr; 26(4):529-534. PubMed ID: 32066976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
    Strydom N; Gupta SV; Fox WS; Via LE; Bang H; Lee M; Eum S; Shim T; Barry CE; Zimmerman M; Dartois V; Savic RM
    PLoS Med; 2019 Apr; 16(4):e1002773. PubMed ID: 30939136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.
    Pienaar E; Cilfone NA; Lin PL; Dartois V; Mattila JT; Butler JR; Flynn JL; Kirschner DE; Linderman JJ
    J Theor Biol; 2015 Feb; 367():166-179. PubMed ID: 25497475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses.
    Lenaerts A; Barry CE; Dartois V
    Immunol Rev; 2015 Mar; 264(1):288-307. PubMed ID: 25703567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging.
    DeMarco VP; Ordonez AA; Klunk M; Prideaux B; Wang H; Zhuo Z; Tonge PJ; Dannals RF; Holt DP; Lee CK; Weinstein EA; Dartois V; Dooley KE; Jain SK
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5768-74. PubMed ID: 26169396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
    Subbian S; Tsenova L; O'Brien P; Yang G; Koo MS; Peixoto B; Fallows D; Dartois V; Muller G; Kaplan G
    PLoS Pathog; 2011 Sep; 7(9):e1002262. PubMed ID: 21949656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secret trumps, impelling the pathogenicity of tubercle bacilli.
    Cardona PJ; Ivanyi J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?
    Lanoix JP; Chaisson RE; Nuermberger EL
    Clin Infect Dis; 2016 Feb; 62(4):484-90. PubMed ID: 26527614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.